Impact of androgen deprivation therapy (ADT) on bone mineral density (BMD) over 3 years in men with nonmetastatic prostate cancer.

被引：0
|
作者：
Alibhai, Shabbir M. H.
Mohamedali, Hassanabbas Z.
Panju, Abbas H.
Timilshina, Narhari
Breunis, Henriette
Canning, Sarah Duff
Fleshner, Neil Eric
Krahn, Murray
Naglie, Gary
Tannock, Ian
Tomlinson, George A.
Warde, Padraig Richard
Cheung, Angela M.
机构：
[1] Univ Hlth Network, Toronto, ON, Canada
[2] Princess Margaret Hosp, Toronto, ON M4X 1K9, Canada
[3] Univ Toronto, THETA, Toronto, ON, Canada
[4] Univ Toronto, Toronto, ON, Canada
[5] Princess Margaret Hosp, Dept Radiat Oncol, Toronto, ON M4X 1K9, Canada
[6] Univ Toronto, Dept Med, Toronto, ON, Canada
[7] Univ Toronto, Dept Med Imaging, Toronto, ON, Canada
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 05期
关键词：
D O I：
10.1200/jco.2012.30.5_suppl.193
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
193
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Management of decreased bone mineral density (BMD) in men starting androgen deprivation therapy (ADT) for prostate cancer
    Panju, A. H.
    Breunis, H.
    Cheung, A. M.
    Duff-Canning, S.
    Fleshner, N. E.
    Krahn, M.
    Naglie, G.
    Tomlinson, G.
    Warde, P.
    Alibhai, S. M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [2] The effect of androgen deprivation therapy (ADT) on bone mineral density (BMD) in men with prostate cancer: A meta-analysis
    Lau, A.
    Vinik, O.
    Alibhai, S. M. H.
    Tomlinson, G.
    Cheung, A. M.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2006, 17 : S141 - S141
  • [3] Impact of 24 months of androgen deprivation therapy (ADT) on physical function in men with nonmetastatic prostate cancer.
    Alibhai, S. M. H.
    Breunis, H.
    Timilshina, N.
    Canning, S. Duff
    Fleshner, N.
    Krahn, M.
    Tannock, I.
    Tomlinson, G. A.
    Warde, P. R.
    Naglie, G.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [4] Androgen deprivation therapy (ADT) and physical function in men with nonmetastatic prostate cancer
    Breunis, H.
    Leach, M.
    Naglie, G.
    Tannock, I. F.
    Fleshner, N. E.
    Krahn, M.
    Duff-Canning, S.
    Tomlinson, G.
    Warde, P.
    Alibhai, S. M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [5] Contemporary analysis of bone mineral density in men initiating androgen deprivation therapy for prostate cancer.
    Hu, Jason
    Aprikian, Armen G.
    Vanhuyse, Marie
    Dragomir, Alice
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (27)
  • [6] Decreases of bone mineral density (BMD) in non-metastatic prostate cancer patients treated with androgen deprivation therapy (ADT)
    Kato, S.
    [J]. INTERNATIONAL JOURNAL OF UROLOGY, 2017, 24 : 104 - 104
  • [7] Bone mineral density in Jamaican men on androgen deprivation therapy for prostate cancer
    Belinda F Morrison
    Ingrid E Burrowes
    William D Aiken
    Richard G Mayhew
    Horace M Fletcher
    Marvin E Reid
    [J]. Infectious Agents and Cancer, 6 (Suppl 2)
  • [8] Toremifene citrate increases bone mineral density in men receiving androgen deprivation therapy for prostate cancer.
    Smith, M. R.
    Chu, F.
    Forrest, J.
    Malkowicz, S. B.
    Price, D.
    Sieber, P.
    Barnette, K. G.
    Segal, S.
    Steiner, M. S.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 229S - 229S
  • [9] Prospective cohort study of depression during androgen deprivation therapy (ADT) for nonmetastatic prostate cancer.
    Timilshina, N.
    Breunis, H.
    Alibhai, S. M. H.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [10] IMPACT OF ANDROGEN DEPRIVATION THERAPY (ADT) ON FATIGUE AMONG MEN WITH PROSTATE CANCER
    Cessna, Julie
    Lee, Morgan
    Donovan, Kristine
    Jim, Heather
    Jacobsen, Paul
    [J]. ANNALS OF BEHAVIORAL MEDICINE, 2012, 43 : S270 - S270
12345